BioCentury
ARTICLE | Clinical News

PA-824: Phase III started

May 18, 2015 7:00 AM UTC

Not-for-profit TB Alliance began the open-label, South African Phase III Nix-TB trial to evaluate the all-oral regimen of PA-824, Sirturo bedaquiline and Zyvox linezolid in about 200 patients ages >...